Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Oxotremorine is an agonist of muscarinic acetylcholine receptors (mAChRs).1 It binds to M1, M2, M3, and M4 mAChRs (Kis = 3.31, 9.33, 5.24, and 7.08 µM, respectively, for the human receptors). It inhibits acetylcholine (ACh; Item No. 23829) release in rat cerebral cortical slices when used at a concentration of 10 µM, an effect that can be reversed by the non-selective mAChR antagonist atropine (Item No. 12008).2 Oxotremorine induces tremors, salivation, and lacrimation in mice (ED50s = 0.11, 0.22, and 0.28 mg/kg).3 It induces analgesia in the hot plate test in mice when administered at a dose of 0.5 mg/kg.4 Oxotremorine has been used to induce parkinsonian symptoms as a model of Parkinson’s disease in mice.5
WARNING This product is not for human or veterinary use.
1. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol. Pharmacol. 52(1), 172-179 (1997).
2. Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine. Nat. New Biol. 241(108), 121-122 (1973).
3. Cholinergic activity of acetylenic imidazoles and related compounds. J. Med. Chem. 34(8), 2314-2327 (1991).
4. Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse. Br. J. Pharmacol. 43(4), 706-714 (1971).
5. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-